Kazuya Masuda
Overview
Explore the profile of Kazuya Masuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masuda K, Iketani S, Liu L, Huang J, Qiao Y, Shah J, et al.
bioRxiv
. 2025 Jan;
PMID: 39868279
Although emerging data have revealed the critical role of memory CD8 T cells in preventing and controlling SARS-CoV-2 infection, virus-specific CD8 T-cell responses against SARS-CoV-2 and its memory and innate-like...
2.
Xu Y, Masuda K, Groso C, Hassan R, Zhou Z, Broderick K, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543973
The COVID-19 outbreak was a global pandemic with wide-ranging healthcare implications. Although several mRNA-based vaccines delivered using lipid nanoparticles (LNP) have been approved and demonstrated efficacy at reducing the severity...
3.
Horii-Hayashi N, Masuda K, Kato T, Kobayashi K, Inutsuka A, Nambu M, et al.
Front Behav Neurosci
. 2024 Jan;
17:1289520.
PMID: 38249128
The security of animal habitats, such as burrows and nests, is vital for their survival and essential activities, including eating, mating, and raising offspring. Animals instinctively exhibit defensive behaviors to...
4.
Xu Y, Ferguson T, Masuda K, Siddiqui M, Smith K, Vest O, et al.
Biomolecules
. 2023 Jul;
13(7).
PMID: 37509124
Developing a safe and effective preventive for HIV-1 remains the hope for controlling the global AIDS epidemic. Recently, mRNA vaccines have emerged as a promising alternative to conventional vaccine approaches,...
5.
Tsuji M, Nair M, Masuda K, Castagna C, Chong Z, Darling T, et al.
Nat Commun
. 2023 Jul;
14(1):3959.
PMID: 37402814
Prophylactic vaccines for SARS-CoV-2 have lowered the incidence of severe COVID-19, but emergence of viral variants that are antigenically distinct from the vaccine strains are of concern and additional, broadly...
6.
Miyamura N, Suzuki K, Friedman R, Floratos A, Kunisada Y, Masuda K, et al.
bioRxiv
. 2023 Jun;
PMID: 37292766
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a tumor immune microenvironment (TIME) that promotes resistance to immunotherapy. A preclinical model system that facilitates studies of the TIME and its impact...
7.
Masuda K, Kornberg A, Miller J, Lin S, Suek N, Botella T, et al.
JCI Insight
. 2022 Feb;
7(7).
PMID: 35192548
Clinical outcomes in colorectal cancer (CRC) correlate with T cell infiltrates, but the specific contributions of heterogenous T cell types remain unclear. To investigate the diverse function of T cells...
8.
Masuda K
BMJ Glob Health
. 2020 Mar;
5(2):e001729.
PMID: 32133186
Introduction: An estimated 216 million cases of malaria occurred worldwide every year. Cross-sectional studies have reported negative association between maternal education and child malaria risks; however, no randomised trial or...
9.
Chalise J, Hashimoto S, Parajuli G, Kang S, Singh S, Gemechu Y, et al.
Proc Natl Acad Sci U S A
. 2019 Jul;
116(30):15128-15133.
PMID: 31289228
Immune cells infiltrate adipose tissues and provide a framework to regulate energy homeostasis. However, the precise underlying mechanisms and signaling by which the immune system regulates energy homeostasis in metabolic...
10.
Sakai Y, Seki N, Hamano H, Ochi H, Abe F, Shimizu F, et al.
Biosci Microbiota Food Health
. 2019 May;
38(2):69-72.
PMID: 31106110
To investigate the prebiotic effect of lactulose at low dosages, we assessed changes in defaecation frequency following ingestion of 1, 2, or 3 g/day of lactulose for 2 weeks. Each...